DJIA 17,269.88 201.01 1.18%
NASDAQ 4,612.28 64.45 1.42%
S&P 500 1,996.13 23.39 1.19%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

Blackstone-backed Catalent sets terms for $871 million IPO

UPDATE 1-Catalent expects IPO to be priced between $19-$22/shr

Tasmania, Big Supplier to Drug Companies, Faces Changes

Taking Cancer Drug With Food May Cut Costs

FDA Panel: 3 Asthma Drugs Can Stay

FDA Panel Seems Skeptical Over Key Avandia Data

Theravance/Glaxo Commence Global Late stage Study on COPD